InterOcean Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,340
Closed -$489K 187
2019
Q1
$489K Sell
3,340
-2,850
-46% -$413K 0.05% 123
2018
Q4
$827K Sell
6,190
-750
-11% -$123K 0.09% 102
2018
Q3
$1.32M Sell
6,940
-63
-0.9% -$11.6K 0.14% 81
2018
Q2
$1.17M Sell
7,003
-4,245
-38% -$682K 0.14% 77
2018
Q1
$1.89M Buy
11,248
+114
+1% +$19.1K 0.25% 61
2017
Q4
$1.82M Buy
11,134
+351
+3% +$63K 0.24% 63
2017
Q3
$2.21M Buy
10,783
+1,155
+12% +$269K 0.33% 55
2017
Q2
$2.34M Buy
9,628
+20
+0.2% +$4.7K 0.38% 52
2017
Q1
$2.3M Buy
9,608
+5,808
+153% +$1.35M 0.42% 49
2016
Q4
$798K Buy
+3,800
New +$787K 0.17% 64

Other funds holding AGN

InterOcean Capital's AGN Position: Q2 2019 in Review

InterOcean Capital sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 3,340 shares — an estimated $489K sold.

InterOcean Capital first reported a position in AGN in Q4 2016 and held it in 10 quarters. The position peaked at $2.34M in Q2 2017. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • InterOcean Capital reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • InterOcean Capital sold 3,340 Allergan plc shares in Q2 2019, an estimated $489K.
  • InterOcean Capital first reported a position in Allergan plc in Q4 2016 and held it in 10 quarters.
  • InterOcean Capital's Allergan plc position peaked at $2.34M in Q2 2017.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on InterOcean Capital's 13F filing for Q2 2019, filed 13 Aug 2019.